Related Experiment Videos
Neurological complications of sickle cell anemia
Insights
Sickle cell disease frequently causes devastating neurological complications, especially cerebral infarction. Long-term transfusion therapy is crucial for preventing recurrent strokes in affected patients.
Area of Science:
- Neurology
- Hematology
- Vascular Medicine
Background:
- Sickle cell hemoglobinopathy presents a significant risk for diverse neurological complications.
- Cerebral infarction is the most frequent, devastating, and debilitating neurological complication, with reported frequencies ranging from 6% to 34%.
Purpose of the Study:
- To discuss the pathogenesis, clinical features, and demography of neurological complications in sickle cell disease.
- To outline diagnostic procedures and management strategies for cerebral infarction.
Main Methods:
- Review of existing literature on neurological complications in sickle cell disease.
- Discussion of diagnostic tools including spinal tap, CT scan, and cerebral angiography.
- Emphasis on transfusion therapy for acute management and recurrence prevention.
Main Results:
- Cerebral infarction is a major cause of morbidity and mortality in sickle cell disease.
- Diagnostic workup should include lumbar puncture and neuroimaging.
- Transfusion therapy is effective in managing acute events and preventing recurrences.
Conclusions:
- Neurological complications, particularly cerebral infarction, are severe in sickle cell disease.
- Prompt diagnosis and aggressive management, including transfusion therapy, are essential.
- Long-term transfusion programs significantly reduce the recurrence of cerebral infarction.
Abstract:
A variety of neurological complications occur with sickle cell hemoglobinopathy. The most striking and most common is cerebral infarction. It is also the most devastating. Because of the high recurrence rate in untreated patients, cerebral infarction is the most debilitating neurological complication. The observed frequency varies from 6% to as high as 34% in different reports. The pathogenesis, clinical features, and demography are discussed. Diagnostic procedures should include a spinal tap to rule out potentially treatable lesions. CT scan and cerebral angiography may also be helpful in certain cases. Transfusion therapy remains the mainstay of management in the acute phase of cerebral infarction. There is considerable evidence to indicate that long-term transfusion programs are effective in the prevention of recurrences. Intracranial hemorrhage, spinal cord infarction, isolated neuropathies due to anatomical proximity to infarcted bones, lead neuropathy, auditory problems, and ocular manifestations are other neurological problems which can affect patients with sickle cell disease.